E6005 in Pediatric Subjects With Atopic Dermatitis

Trial Profile

E6005 in Pediatric Subjects With Atopic Dermatitis

Phase of Trial: Phase I/II

Latest Information Update: 01 Mar 2018

At a glance

  • Drugs Lotamilast (Primary)
  • Indications Atopic dermatitis
  • Focus Adverse reactions; Pharmacokinetics
  • Sponsors Eisai Inc
  • Most Recent Events

    • 11 Mar 2015 Status changed from recruiting to complete, according to ClinicalTrials.gov record.
    • 16 Jul 2014 Planned number of patients changed from 60 to 24 as reported by ClinicalTrials.gov.
    • 25 Mar 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top